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The authors respond to a comment by Alvisi & Jans [(2014), Acta Cryst. D70,
2775–2776] on the article Phosphorylation adjacent to the nuclear localization
signal of human dUTPase abolishes nuclear import: structural and mechanistic
insights [Ro´na et al. (2013), Acta Cryst. D69, 2495–2505].
Nucleo-cytoplasmic trafficking of proteins is tightly regulated in a
number of ways (Poon & Jans, 2005; Pouton et al., 2007; Sekimoto &
Yoneda, 2012). Post-transcriptional modifications play a key role in
these regulatory processes, and phosphorylation can either enhance
or reduce nuclear accumulation (Jans, 1995; Nardozzi et al., 2010).
Phosphorylation in the vicinity of nuclear localization signals (NLSs)
can affect the binding affinity between the cargoes and their nuclear
transport receptors. A negative charge in the proximity to the posi-
tively charged NLS can diminish its recognition by importin-, while
it might have an enhancing effect if positioned further upstream of
the NLS (Alvisi et al., 2008; Fontes et al., 2003; Harreman et al., 2004;
Hu¨bner et al., 1997; Kosugi et al., 2008, 2009; Marfori et al., 2012).
Until now, however, no clear crystallographic model has been avail-
able explaining how phosphorylation inhibits cargo protein binding
to importin-. The crystallographic model presented in our study has
now shed light on a structural mechanism that lies behind the
phosphorylation-mediated inhibition of nuclear import (Ro´na et al.,
2013).
Recent studies have shown that the cytoplasmic retention factor
BRAP2 can recognize NLSs or NLS-like sequences upon phos-
phorylation, and therefore can affect the localization pattern of
several viral and cellular proteins (Fulcher et al., 2010; Li et al., 1998).
However, even overexpressed BRAP2 was not able to completely
block its binding partners (either endogenous or also overexpressed)
from entering the nucleus, since these binding partners still remained
mainly nuclear. BRAP2 therefore appears to have mainly a fine-
tuning function in determining the nuclear levels of its binding
partners (Fulcher et al., 2010).
Nevertheless, the involvement of BRAP2 in the cytoplasmic
localization of the NLS phosphorylated (S11) dUTPase (Ladner et
al., 1996; Ro´na et al., 2013; Takacs et al., 2009; Tinkelenberg et al.,
2003), as suggested by Alvisi & Jans (2014), is an interesting
hypothesis but could only be answered after careful experimental
testing. Our unpublished preliminary experiments aiming at identi-
fying the binding partners of human dUTPase did not detect BRAP2
as its binding partner, although further confirmation of this result is
needed. Even though the classical monopartite NLS (class 2) (Kosugi
et al., 2009) of dUTPase resembles some of the phospho-NLSs
BRAP2 binds (ppUL44, T-ag, p53), the phosphorylatable moiety is
positioned differently relative to the positively charged cluster.
Alvisi & Jans (2014) argue that mechanisms other than the phos-
phorylation affecting binding to importin- may be responsible for
the cytoplasmic localization profile of phosphorylated dUTPase,
because the hyperphosphorylation mimicking mutation (S11E) only
impairs the Kd value of the dUTPase:importin- interaction by# 2014 International Union of Crystallography
tenfold. They suggest that according to the work of Hodel et al. (2001)
and Harreman et al. (2004), only mutations resulting in changes of
two orders of magnitude in the affinity constant would have a
significant impact on nuclear translocation. Based on the available
literature, we are of the opinion that this is a somewhat oversimplified
interpretation of the issue. Hodel and coworkers (Hodel et al., 2001)
established that functional NLSs have dissociation constants for
importin- binding in the range of 10 nM to 1 mM. This is a rather
wide range of values and what most likely matters for a particular
NLS is where its affinity lies within this range, rather than the
magnitude of the effect of phosphorylation, i.e. whether the phos-
phorylation moves the affinity over the threshold so it falls outside
the functional range. If the affinity of a certain cargo:importin-
interaction is close to the low affinity limit for a functional NLS, a
small difference can have a considerable effect. On the other hand, if
the Kd value is close to the high affinity limit, a much more substantial
alteration of the NLS would be required to make it non-functional.
Alvisi & Jans (2014) suggest that based on the results of Harreman
et al. (2004), a tenfold difference in binding affinity would not by itself
explain the strong impact of the S11E mutation on the cellular
localization observed in our study (Ro´na et al., 2013). However, the
data in the same study clearly indicates (Harreman et al., 2004) that
affinity differences of less than tenfold could lead to drastic changes
in the localization of the cargo protein. The wild-type SV40 large T-
antigen NLS derivative used in their study (SPKKKRKAE, termed
SV40A7) had a Kd value for IBB-importin- of 80 nM, while its
hyperphosphorylation mimicking mutant variant (EPKKKRKAE,
termed SV40A7E) had a Kd value of 283 nM, as determined in vitro
by a GFP anisotropy-based binding assay. The ability of the SV40A7
NLS to drive a GFP reporter construct to the nucleus was validated in
vivo in yeast. However, the SV40A7E mutant was not imported into
the nucleus, despite the just 3.5-fold affinity difference compared to
the wild-type NLS. The NLS of Swi6 was also tested in a similar
manner. The wild-type NLS (SPLKKLKID) had a Kd value of 26 nM,
while the hyperphosphorylation mimicking mutant (EPLKKLKID)
had a Kd value of 124 nM. The mutant NLS was not able to drive GFP
accumulation into the nucleus, although the affinity difference was
only 4.8-fold. The authors also used the full-length sequence of Swi6
fused to GFP to validate their results. The wild-type Swi6 protein had
a Kd value of 45 nM, while the Kd value of the phosphorylation-
mimicking mutant was 163 nM. The phosphorylation-mimicking
mutant was not able to enter the nucleus in vivo, despite only a 3.5-
fold difference in the Kd value compared to the wild-type Swi6, which
was able to enter the nucleus in the G1 phase (Harreman et al., 2004).
We believe that our data are in agreement with previous reports in
the literature, and that a tenfold affinity difference between the
phosphorylation-mimicking (S11E) and wild-type dUTPase for
importin- could realistically be the sole reason for the nuclear
exclusion of the phosphorylation-mimicking protein. However, the
data certainly allow the possibility that cytoplasmic retention factors,
such as BRAP2, could contribute to the fine-tuning of the localization
pattern of dUTPase. This possibility will need to be investigated
experimentally.
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